Developing a new medicine is historically a grueling process, often taking over a decade and costing billions of dollars. To fix this, pharmaceutical companies are using artificial intelligence (AI) to fundamentally transform every step of drug development, cutting total costs by up to 40% and slashing development timelines in half. Instead of years of manual lab work, AI can screen billions of chemical compounds in months, accurately predict toxic side effects to eliminate up to 40% of animal testing, and use “digital twin” simulations to safely reduce the number of human patients needed for clinical trials. While hurdles like data quality, algorithmic bias, and regulatory approvals still need to be addressed, this technology is successfully shifting medicine away from slow, trial-and-error experimentation and toward a faster, more predictable future for lifesaving treatments.